CG
CVAC

Cutler Group’s CureVac CVAC Stock Holding History

Cutler Group’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1K Hold
600
– – ﹤0.01% 1975
2023
Q4 		$2K Hold
600
– – ﹤0.01% 3075
2023
Q3 		$4K Hold
600
– – ﹤0.01% 2934
2023
Q2 		$6K Sell
600
-100
-14% -$894 ﹤0.01% 2515
2023
Q1 		$4K Sell
700
-200
-22% -$1.74K ﹤0.01% 2808
2022
Q4 		$5K Hold
900
– – ﹤0.01% 3146
2022
Q3 		$7K Sell
900
-200
-18% -$2.33K ﹤0.01% 3367
2022
Q2 		$14K Buy
+1,100
New +$18.2K ﹤0.01% 2937
2022
Q1 		– Sell
-6,840
Closed -$137K – 5428
2021
Q4 		$234K Buy
6,840
+2,926
+75% +$118K 0.01% 1194
2021
Q3 		$213K Sell
3,914
-1,122
-22% -$67.6K 0.01% 1318
2021
Q2 		$370K Sell
5,036
-9,064
-64% -$906K 0.02% 917
2021
Q1 		$1.29M Sell
14,100
-3,700
-21% -$359K 0.06% 341
2020
Q4 		$1.44M Sell
17,800
-600
-3% -$45.9K 0.07% 286
2020
Q3 		$856K Buy
+18,400
New +$1.03M 0.05% 365

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Cutler Group's CVAC Position: Q1 2024 in Review

Cutler Group held its CureVac (CVAC) position steady in Q1 2024 at 600 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Cutler Group first reported a position in CVAC in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.44M in Q4 2020. 90 funds tracked by Wall St. Rank hold CVAC as of Q1 2024.

  • Cutler Group held 600 shares of CureVac worth $1K as of Q1 2024.
  • Cutler Group left its CureVac share count unchanged in Q1 2024.
  • CureVac made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1975 holding.
  • Cutler Group first reported a position in CureVac in Q3 2020 and has held it in 14 quarters since.
  • Cutler Group's CureVac position peaked at $1.44M in Q4 2020.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.